Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Eurozone GDP data lifts markets as resource stocks rise

Fri, 13th Feb 2015 11:37

Stronger-than-expected Eurozone growth figures and easing concerns about Ukraine and Greece gave stocks a boost in London on Friday, with resource shares leading the advance.The FTSE 100 was trading 0.6% higher at 6,869 by midday, as metal and oil stocks tracked commodity prices higher.Eurozone gross domestic product (GDP) growth picked up to 0.3% in the fourth quarter of 2014 from 0.2% in the third quarter, surprising analysts who had expected the rate of expansion to remain unchanged.German GDP came in particularly strong, expanding by 0.7% in the fourth quarter from 0.1% the preceding three months, well ahead of the 0.3% growth predicted in Europe's largest economy.The better-than-expected data will come as welcome news for the European Central Bank president Mario Draghi, who faced an uphill task in trying to steer the Eurozone out of deflation."Mario Draghi has bought himself a bit of time, as year-on-year figures show small signs of Eurozone growth following the significant bond buying programme he announced recently," Dennis de Jong, managing director at UFX.com.Concerns about the Ukraine crisis have also eased after the country agreed to a ceasefire with Russia after tense negotiations in Minsk. However, there was continued fighting overnight in the rebel-held cities of eastern Ukraine, with the ceasefire not expected to kick in until Sunday."Investors also appear confident that a Greek disaster can also be averted on unconfirmed reports that German and Greek officials were working on a compromise in Brussels as both sides looked to soften their positions," said analyst Michael Hewson from CMC Markets. The speculation comes before the next Eurogroup meeting scheduled to begin on Monday.Anglo leads miners higherThe share price of Anglo American advanced despite the news that it has decided to write-down the value of certain assets by $3.9bn on the back of weaker iron ore prices, pushing the company into the red for the 2014 financial year. Anglo swung to a pre-tax loss of $259m in 2014, compared with a profit of $1.7bn in 2013.Other miners were also in positive territory, including BHP Billiton, Glencore and Rio Tinto, as metal prices improved. Even Fresnillo gained despite explaining how foreign exchange movements, depreciation and write-downs would adversely affect its 2014 results.Oil stocks such as Tullow, BG and Premier Oil were also in demand was Brent crude continued its rebound and was trading above $60 a a barrel for the first time in 2015.Glaxosmithkline's shares were given a boost by UBS which upgraded its rating for the pharmaceutical stock by two notches from 'sell' to 'buy', saying that the business is now at an "inflection point" after a tough few years. The bank hiked its target price for the stock from 1,250p to 1,700p,Utilities group Severn Trent declined after saying that while it is on track to hit expectations this financial year, operating costs are expected to rise due to the impact of inflation and quasi taxes.Rolls-Royce also fell despite the engine maker meeting forecasts with its 2014 results, as it said it expects profits to fall further this year as customers face "increased uncertainty" from weaker oil prices.Shire edged higher after a strong jump the previous session following its fourth-quarter results. The pharma group was also in focus on speculation it is preparing to make a bid for US peer Salix Pharmaceuticals, worth $9.2bn at current market prices.Market MoverstechMARK 3,126.19 +0.32%FTSE 100 6,869.16 +0.60%FTSE 250 16,894.80 +0.51%FTSE 100 - RisersTullow Oil (TLW) 403.20p +4.70%Glencore (GLEN) 288.30p +4.12%BHP Billiton (BLT) 1,554.00p +3.98%GlaxoSmithKline (GSK) 1,544.50p +3.97%Anglo American (AAL) 1,206.50p +3.52%Rio Tinto (RIO) 3,139.00p +3.27%Antofagasta (ANTO) 728.50p +3.26%BG Group (BG.) 962.80p +3.04%Weir Group (WEIR) 1,889.00p +2.66%Barclays (BARC) 258.75p +2.13%FTSE 100 - FallersBT Group (BT.A) 440.10p -2.20%United Utilities Group (UU.) 954.00p -1.95%easyJet (EZJ) 1,708.00p -1.95%InterContinental Hotels Group (IHG) 2,623.00p -1.58%SSE (SSE) 1,577.00p -1.44%ARM Holdings (ARM) 1,070.00p -1.38%Ashtead Group (AHT) 1,086.00p -1.27%National Grid (NG.) 883.50p -1.24%Severn Trent (SVT) 2,033.00p -1.17%Sage Group (SGE) 469.70p -1.05%FTSE 250 - RisersAfren (AFR) 8.26p +16.17%Vedanta Resources (VED) 523.50p +10.68%Premier Oil (PMO) 167.70p +5.54%RPS Group (RPS) 239.20p +5.42%Kaz Minerals (KAZ) 256.80p +4.26%Evraz (EVR) 194.30p +3.74%BlackRock World Mining Trust (BRWM) 331.60p +3.46%Atkins (WS) (ATK) 1,355.00p +3.04%Lonmin (LMI) 161.60p +2.93%Oxford Instruments (OXIG) 735.50p +2.87%FTSE 250 - FallersAO World (AO.) 285.90p -6.14%Supergroup (SGP) 1,022.00p -3.49%Bwin.party Digital Entertainment (BPTY) 99.05p -3.37%Acacia Mining (ACA) 273.40p -2.74%Hunting (HTG) 494.10p -1.77%Ocado Group (OCDO) 385.00p -1.53%Euromoney Institutional Investor (ERM) 985.00p -1.50%Go-Ahead Group (GOG) 2,422.00p -1.30%Rank Group (RNK) 184.70p -1.23%TalkTalk Telecom Group (TALK) 319.90p -1.17%
More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.